| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novartis AG (NVS) has 0 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. NVS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 19,550 | $10.06 | $196,673.00 | -0.9% | |
| May 10, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 73,955 | $10.12 | $748,139.55 | -1.6% | |
| May 8, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 42,105 | $10.06 | $423,556.99 | -0.9% | |
| Apr 23, 2018 | Novartis Institutes For Biomedical Research, Inc. | 10% Owner | Buy | 766,666 | $15.00 | $11,499,990.00 | +24.1% | |
| Dec 12, 2017 | Novartis Institutes For Biomedical Research, Inc. | 10% Owner | Sell | 1,523,000 | $18.30 | $27,870,900.00 | -26.9% | |
| Jul 5, 2017 | Novartis Bioventures Ltd | 10% Owner | Buy | 266,667 | $15.00 | $4,000,005.00 | +11.7% | |
| Jun 19, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 56,420 | $21.29 | $1,201,106.00 | -1.2% | |
| Jun 8, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 700 | $22.00 | $15,400.00 | - | |
| Jun 7, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 12,114 | $22.63 | $274,160.22 | -0.3% | |
| Jun 5, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 19,647 | $23.38 | $459,437.09 | -0.4% |